Linda L. Neuman
Chief Medical Officer, Aeglea BioTherapeutics.
Companies
- Aeglea BioTherapeuticsChief Medical Officer Jan 27, 2023 to Feb 24, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aeglea BioTherapeutics SYRE4,000 shares2$342.3K at $85.57Jan 27, 2023
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2